October 31, 2023 — SMT (Sahajanand Medical Technologies), a leading medical device company in India, focused on ...
October 31, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 30, 2023 — Shockwave Medical, Inc., which develops technologies for the treatment of cardiovascular disease, has ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 30, 2023 — Boston Scientific Corporation on Friday announced positive 12-month results from the pivotal AGENT ...
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...
October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...
October 26, 2023 — Abbott announced data from late-breaking presentations showing the impact of its minimally invasive ...
October 26, 2023 — HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 26, 2023 — The Society of Thoracic Surgeons and the European Association for Cardiothoracic Surgeons have issued ...
October 26, 2023 — A new study presented at TCT 2023 revealed inequities in access to mechanical circulatory support in ...
October 25, 2023 — Elixir Medical, developer of novel cardiovascular technologies, announced positive six-month clinical ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 25, 2023 — Medtronic plc, a global leader in healthcare technology, announced four-year results from the Evolut ...
October 25, 2023 — Edwards Lifesciences announced new data from the PARTNER 3 trial demonstrating continued low rates of ...
October 25, 2023 — Data from the REAL-PE study was presented today at Transcatheter Cardiovascular Therapeutics(TCT) ...